ADVERTISEMENT
Search

 

Press Releases

 

26

May

2022

APhA statement on Texas Mass Shooting

WASHINGTON, DC—The American Pharmacists Association (APhA) is deeply saddened by the horrific mass shooting in Uvalde, Texas, elementary school in which a gunman took the lives of at least 19 young children and two dedicated teachers.

Comments (0)
Number of views (2806)
Article rating: No rating

2

May

2022

APhA appreciates CMS’ elimination of retroactive DIR fees

Though more actions are needed to address PBMs’ harmful business practices

Author: Renee Kalu

WASHINGTON, D.C.—CMS has issued a final rule eliminating Part D plans’ and PBMs’ use of retroactive direct and indirect remuneration (DIR) fees beginning on January 1, 2024 (contract year 2024). The American Pharmacists Association (APhA) and many of its members submitted comments to CMS on the proposal. APhA appreciates CMS’ efforts to end the uncertainty and lack of drug cost transparency at the pharmacy caused by retroactive DIR fees.

Comments (0)
Number of views (7806)
Article rating: No rating

22

Apr

2022

APhA addresses AMA’s inaccurate description of H.R. 7213 and viewpoints of most physicians working alongside pharmacists

Author: Renee Kalu

WASHINGTON, DC – The American Pharmacists Association released the following statement in response to an April 12, 2022, letter from the American Medical Association (AMA) to Representatives Kind and McKinley regarding H.R. 7213, the “Equitable Community Access to Pharmacist Services Act.”  

Comments (0)
Number of views (11747)
Article rating: No rating

13

Apr

2022

APhA releases Community Pharmacy Workplace Summit Report to address drivers impacting workplace and well-being

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that results in improved workplaces, well-being, and the ability to meet ethical obligations to patient safety. 

Comments (0)
Number of views (4555)
Article rating: No rating

7

Mar

2022

New Study: Medicare could save seniors billions by fixing Part D incentives

Author: Renee Kalu

WASHINGTON, DC and BESSEMER, AL—Plan sponsors and PBMs who manage prescription drug benefits under Medicare Part D are shifting costs and risks to America’s seniors and taxpayers by artificially inflating prescription drug costs at the pharmacy counter, according to a groundbreaking new study released today.

Comments (0)
Number of views (5704)
Article rating: No rating
RSS
First1011121314151719
ADVERTISEMENT